Cargando…
Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition
Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. Given its rarity, the genomic landscape, clinical course, and prognosis of NSSM are...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969947/ https://www.ncbi.nlm.nih.gov/pubmed/33731690 http://dx.doi.org/10.1038/s41525-021-00186-9 |
_version_ | 1783666335353405440 |
---|---|
author | Masood, Ashiq Christ, Trevor Asif, Samia Rajakumar, Priya Gustafson, Beth A. Shune, Leyla O. Salahudeen, Ameen Nedvad, Drew Nanua, Suparna Paner, Agne Kuzel, Timothy M. Levy, Mia Subramanian, Janakiraman Raza, Shahzad |
author_facet | Masood, Ashiq Christ, Trevor Asif, Samia Rajakumar, Priya Gustafson, Beth A. Shune, Leyla O. Salahudeen, Ameen Nedvad, Drew Nanua, Suparna Paner, Agne Kuzel, Timothy M. Levy, Mia Subramanian, Janakiraman Raza, Shahzad |
author_sort | Masood, Ashiq |
collection | PubMed |
description | Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. Given its rarity, the genomic landscape, clinical course, and prognosis of NSSM are not well characterized. Here, we report a case of a patient with relapsed and refractory NSMM with brain metastasis harboring a TFG-ALK fusion showing a dramatic and durable (over two years) response to commercially available anaplastic lymphoma kinase (ALK) inhibitors. The case emphasizes the beneficial role of molecular profiling in this target-poor disease. |
format | Online Article Text |
id | pubmed-7969947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79699472021-04-12 Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition Masood, Ashiq Christ, Trevor Asif, Samia Rajakumar, Priya Gustafson, Beth A. Shune, Leyla O. Salahudeen, Ameen Nedvad, Drew Nanua, Suparna Paner, Agne Kuzel, Timothy M. Levy, Mia Subramanian, Janakiraman Raza, Shahzad NPJ Genom Med Case Report Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. Given its rarity, the genomic landscape, clinical course, and prognosis of NSSM are not well characterized. Here, we report a case of a patient with relapsed and refractory NSMM with brain metastasis harboring a TFG-ALK fusion showing a dramatic and durable (over two years) response to commercially available anaplastic lymphoma kinase (ALK) inhibitors. The case emphasizes the beneficial role of molecular profiling in this target-poor disease. Nature Publishing Group UK 2021-03-17 /pmc/articles/PMC7969947/ /pubmed/33731690 http://dx.doi.org/10.1038/s41525-021-00186-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Case Report Masood, Ashiq Christ, Trevor Asif, Samia Rajakumar, Priya Gustafson, Beth A. Shune, Leyla O. Salahudeen, Ameen Nedvad, Drew Nanua, Suparna Paner, Agne Kuzel, Timothy M. Levy, Mia Subramanian, Janakiraman Raza, Shahzad Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition |
title | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition |
title_full | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition |
title_fullStr | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition |
title_full_unstemmed | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition |
title_short | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition |
title_sort | non-secretory multiple myeloma with unusual tfg-alk fusion showed dramatic response to alk inhibition |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969947/ https://www.ncbi.nlm.nih.gov/pubmed/33731690 http://dx.doi.org/10.1038/s41525-021-00186-9 |
work_keys_str_mv | AT masoodashiq nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT christtrevor nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT asifsamia nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT rajakumarpriya nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT gustafsonbetha nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT shuneleylao nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT salahudeenameen nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT nedvaddrew nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT nanuasuparna nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT paneragne nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT kuzeltimothym nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT levymia nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT subramanianjanakiraman nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition AT razashahzad nonsecretorymultiplemyelomawithunusualtfgalkfusionshoweddramaticresponsetoalkinhibition |